Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | How machine learning models may play a role in therapy selection for multiple myeloma

Jamin Koo, PhD, Stanford University, Stanford, CA, comments on how machine learning models may be used to improve treatment selection in patients with multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Cofounder of ImpriMed